Roche succeeds in mid-stage trial for obesity drug developed with Zealand
Source: SeekingAlpha
2026-03-05 14:13:20 ET
More on Roche Holding, Zealand Pharma
- Zealand Pharma A/S 2025 Q4 - Results - Earnings Call Presentation
- Zealand Pharma A/S (ZLDPF) Q4 2025 Earnings Call Transcript
- Roche Holding AG (RHHBY) Shareholder/Analyst Presentation
- Roche CEO Schinecker wants a bite of the weight loss drugs market
- ClearBridge International Growth ACWI Ex-US Strategy adds and exits multiple positions
Read the full article on Seeking Alpha
For further details see:
Roche succeeds in mid-stage trial for obesity drug developed with Zealand
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
2.52% G/L:
$54.26 Last:
721,223 Volume:
$54.18 Open:
RHHBY Latest News
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
